Streetbeat News

Products Services

ABBV

GMAB

Genmab A/S (NASDAQ:GMAB) and AbbVie Inc (NYSE:ABBV) have announced positive topline results from the follicular lymphoma cohort of the phase 1/2 EPCORE NHL-1 clinical trial evaluating epcoritamab. The study showed an overall response rate of 82%, exceeding the protocol-prespecified threshold for efficacy. The companies will engage with global regulatory authorities to determine the next steps.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 10:50 am

OPK

PFE

The FDA has approved Ngenla, a once-weekly human growth hormone analog for pediatric patients with growth failure, developed in partnership between Pfizer and OPKO Health.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 10:48 am

LQDA

Liquidia and Pharmosa Biopharm have entered into an exclusive licensing agreement for the development and commercialization of L606 in North America. Liquidia will pay $10M upfront and $215M in milestone payments. L606 is an inhaled, sustained-release formulation of treprostinil, currently under clinical trial for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 9:52 am

RIO

Rio Tinto, a mining company, plans to build batteries in Melbourne to test green technology. This move is part of the company's efforts to transition towards more sustainable operations.

Portfolio Pulse from Charles Gross

June 28, 2023 | 9:21 am

GOOG

GOOGL

MSFT

YouTuber MrBeast (Jimmy Donaldson) has expressed optimism about the potential of AI chatbots like OpenAI's chatGPT, dismissing fears of AI replacing human jobs. He envisions a future where AI can generate suggestions for content creation, serving as a source of inspiration. He also plans to explore AI's capabilities in the future. The release of chatGPT has sparked debates about AI's impact on the workforce and ignited competition among tech giants like Alphabet Inc. and Microsoft Corporation.

Portfolio Pulse from Ananya Gairola

June 28, 2023 | 9:17 am

AAPL

Apple Inc. has increased the prices of its iCloud storage services by up to 28% in the UK and several other countries. The price hike affects all three storage tiers – 50GB, 200GB, and 2TB. iCloud+ users will now have to pay more for storage in countries including the UK, UAE, Saudi Arabia, South Africa, Sweden, Turkey, Poland, Romania, and Tanzania.

Portfolio Pulse from Rounak Jain

June 28, 2023 | 9:13 am

ABBV

GMAB

Abbvie and Genmab have announced the topline results from the follicular lymphoma cohort of the phase 1/2 EPCORE NHL-1 trial of Epcoritamab. The companies are planning to engage with regulatory authorities to discuss the next steps.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 8:12 am

RETA

The FDA has approved the Prior Approval Supplement for Reata Pharmaceuticals' drug, Skyclarys (Omaveloxolone), for Friedreich's Ataxia in adults and adolescents. With this approval, Skyclarys is now available in the US.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 8:08 am

SBUX

Starbucks (NASDAQ:SBUX) is launching a new clear coffee drink, Coffeeade Cool Lime, in all its stores in Japan this summer. The drink, which was successfully launched at Starbucks Reserve Roastery Tokyo last summer, uses a special method to extract the coffee flavor. Two new Coffeeades, Orange Delight and Lime Mint, will be exclusive to the Roastery.

Portfolio Pulse from Benzinga Newsbot

June 28, 2023 | 8:00 am

LAES

WKEY

WISeKey International Holding Ltd. and its subsidiary SEALSQ Corp. announced plans to enhance the security infrastructure of semiconductors and the IoT ecosystem using Generative Pre-trained Transformer (GPT) capabilities.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 7:31 am